A Study on the Immune Response and Safety of a Combined Vaccine Against Diphtheria, Tetanus and Acellular Pertussis (dTpa) in Japanese Healthy Pregnant Women | MicrobiomeTrials
A Study on the Immune Response and Safety of a Combined Vaccine Against Diphtheria, Tetanus and Acellular Pertussis (dTpa) in Japanese Healthy Pregnant Women
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2026-06-29Est. Completion: 2026-11-23
Enrollment target: 102 participants
Locations
GSK Investigational Site, Aichi, Japan
GSK Investigational Site, Chiba, Japan
GSK Investigational Site, Chiba, Japan
GSK Investigational Site, Fukui, Japan
GSK Investigational Site, Fukuoka, Japan
GSK Investigational Site, Fukushima, Japan
GSK Investigational Site, Hokkaido, Japan
GSK Investigational Site, Kanagawa, Japan
GSK Investigational Site, Kanagawa, Japan
GSK Investigational Site, Kyoto, Japan
GSK Investigational Site, Nagano, Japan
GSK Investigational Site, Nara, Japan
GSK Investigational Site, Osaka, Japan
GSK Investigational Site, Osaka, Japan
GSK Investigational Site, Saitama, Japan
GSK Investigational Site, Saitama, Japan
GSK Investigational Site, Shizuoka, Japan
GSK Investigational Site, Shizuoka, Japan
GSK Investigational Site, Tokyo, Japan
GSK Investigational Site, Tokyo, Japan
Other microbiome trials you might be interested in